Nath Bio-Genes (I) Ltd

NATHBIOGEN
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹367 cr, stock is ranked 1,389
Moderate RiskStock is 2.41x as volatile as Nifty
193.352.40 (+1.26%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Consumer StaplesAgro Products
SmallcapWith a market cap of ₹367 cr, stock is ranked 1,389
Moderate RiskStock is 2.41x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
6.60
PB RatioPB Ratio
0.60
Dividend YieldDiv. Yield
1.03%
Sector PESector PE
42.99
Sector PBSector PB
8.83
Sector Div YldSctr Div Yld
1.64%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Nath Bio-Genes (India) is engaged in hybrid seed business and production, processing and marketing of hybrid and genetically modified (GM) seeds

Investor PresentationView older 

Feb 14, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021192.59233.20281.71309.2329.4338.4250.4955.65
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 2.31%

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Schedule of Analysts/Institutional Investor Meet/Con. Call 
Announced OnMay 27, 2022

Nath Bio-Genes (India) Limited has informed the Exchange about Schedule of Con. Call to be held on 30th May 2022 | Download

Nath Bio-Genes (India) Limited has informed the Exchange about Schedule of Con. Call to be held on 30th May 2022 | Download

General updates 
Announced OnApr 20, 2022

Nath Bio-Genes (India) Limited has informed the Exchange about the Certificate under Reg 74(5) of SEBI (DP) Regulations | Download

Nath Bio-Genes (India) Limited has informed the Exchange about the Certificate under Reg 74(5) of SEBI (DP) Regulations | Download

Cash Dividend 
Ex. DateAug 18, 2021

Final • Div/Share: ₹ 2

See all events